Found: 27
Select item for more details and to access through your institution.
Prevalence of Potential Drug–Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. e2145, doi. 10.1093/cid/ciaa918
- By:
- Publication type:
- Article
Polypharmacy and Drug–Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 2, p. 353, doi. 10.1093/cid/ciz811
- By:
- Publication type:
- Article
Recognition of Risk for Clinically Significant Drug Interactions among HIV-Infected Patients Receiving Antiretroviral Therapy.
- Published in:
- Clinical Infectious Diseases, 2010, v. 50, n. 10, p. 1419, doi. 10.1086/652149
- By:
- Publication type:
- Article
Association of a Single-Nucleotide Polymorphism in the Pregnane X Receptor (PXR 63396CrT) with Reduced Concentrations of Unboosted Atazanavir.
- Published in:
- Clinical Infectious Diseases, 2008, v. 47, n. 9, p. 1222, doi. 10.1086/592304
- By:
- Publication type:
- Article
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 6, p. 1354
- By:
- Publication type:
- Article
Factors influencing lopinavir and atazanavir plasma concentration.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 1, p. 129, doi. 10.1093/jac/dkp408
- By:
- Publication type:
- Article
Erratum.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2002, v. 49, n. 1, p. 227
- By:
- Publication type:
- Article
Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Drug–Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 3, p. 339, doi. 10.1007/s40262-021-01098-8
- By:
- Publication type:
- Article
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 7, p. 835, doi. 10.1007/s40262-021-01005-1
- By:
- Publication type:
- Article
Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenya Cohort.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0016800
- By:
- Publication type:
- Article
Pharmacokinetic Interactions of Nevirapine and Methadone and Guidelines for Use of Nevirapine to Treat Injection Drug Users.
- Published in:
- Clinical Infectious Diseases, 2001, v. 33, n. 9, p. 1595, doi. 10.1086/322519
- By:
- Publication type:
- Article
Response to ‘Communicating Information about Drug Interactions’.
- Published in:
- 2008
- By:
- Publication type:
- Letter
The role of therapeutic drug monitoring in treatment of HIV infection.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 52, p. 89S, doi. 10.1046/j.1365-2125.2001.00380.x
- By:
- Publication type:
- Article
The role of therapeutic drug monitoring in treatment of HIV infection.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 4, p. 301, doi. 10.1046/j.1365-2125.2001.01380.x
- By:
- Publication type:
- Article
The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 3
- By:
- Publication type:
- Article
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
- Published in:
- Drugs in R&D, 2021, v. 21, n. 1, p. 9, doi. 10.1007/s40268-020-00333-0
- By:
- Publication type:
- Article
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0173509
- By:
- Publication type:
- Article
Potential drug–drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 5, p. 1541, doi. 10.1111/bcp.15614
- By:
- Publication type:
- Article
COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 1, p. 212, doi. 10.1111/bcp.14358
- By:
- Publication type:
- Article
Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1191, doi. 10.1002/cpt.2646
- By:
- Publication type:
- Article
DeepARV: ensemble deep learning to predict drug-drug interaction of clinical relevance with antiretroviral therapy.
- Published in:
- NPJ Systems Biology & Applications, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41540-024-00374-0
- By:
- Publication type:
- Article
GLOBAL COLLABORATION TO PROVIDE DRUG INTERACTION GUIDANCE FOR NIRMATRELVIR/RITONAVIR.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 202
- By:
- Publication type:
- Article
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications.
- Published in:
- 2016
- By:
- Publication type:
- journal article